We are excited to announce programs designed to expand access to genetic testing for patients who have been unable to access testing because of financial barriers.
Rare Genomics Institute (RG) is happy to partner with leading genetic sequencing laboratory Illumina Inc. (NASDAQ: ILMN) as part of their iHope program, which provides free trio clinical whole genome sequencing to children affected by rare or undiagnosed diseases. Romina Ortiz, MHS, Co-founder, COO and VP of Patient Advocacy, is leading this operation for Rare Genomics. See a short video about iHope here.
Who is eligible?
Children who are suspected of having a rare or undiagnosed disease, who have two biologic parents who can also provide a blood sample and a physician that recommends the test.
Is there a cost associated?
There are no costs for the sequencing and interpretation. There may be cost associated with visiting your physician and drawing samples that you will be responsible for.
How long will it take to get results and will they be private?
In an estimated 90 days the results will be sent to your referring physician.
How do I apply?
Complete our RG application and a member of our Patient Advocacy Team will contact you for next steps to determine eligibility.